利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

16 条记录 (耗时 0.019 秒)

    Detachable combination instrument for health-care and treatment
    1.
    发明授权
    Detachable combination instrument for health-care and treatment 失效

    公开(公告)号：US06733436B2

    公开(公告)日：2004-05-11

    申请号：US10292892

    申请日：2002-11-12

    申请人： Jian Wang ,  Jingyi Wang

    发明人： Jian Wang ,  Jingyi Wang

    IPC分类号： A61N100

    CPC分类号： A61N2/02 ,  A61N2/002 ,  A61N2005/066 ,  Y10S601/04

    摘要： Disclosed is a detachable combination health-care and treatment instrument has a optimal matching parameter, fits the shape of different parts of body, can be used in several parts of body simultaneously, and possesses a energy field multiplexed by a permanent magnetic field, a pulse magnetic field, a thermal effect and far infrared rays. It relates to a health-care and treatment instrument. The instrument includes a main unit, panel units and soft units. In the case of the panel unit, the magnetic induction intensity is 100˜130 mT, the inductance of the coil and the core is 30˜80 mH, and the impedance of the heater panel is 3˜5&OHgr;. In the case of the soft unit, the magnetic induction intensity is ≧100 mT, the inductance of the coil and the core is 30˜80 mH, and the impedance of the sheet heater is 7˜9&OHgr;. Since the present invention has a plurality of panel units and soft units, several parts of body can be positioned into a multiplex energy field simultaneously so that the communication effect of the venation gets better. Furthermore, since it has the optimal matching parameter and adapts the said multiplex energy field to the body so as to achieve the perfect effect of jingluo conduction and health care.

    Dynamic and static magnetic pulse physical therapeutic apparatus
    2.
    发明授权
    Dynamic and static magnetic pulse physical therapeutic apparatus 失效
    动静磁脉冲物理治疗仪

    公开(公告)号：US07309309B2

    公开(公告)日：2007-12-18

    申请号：US10663988

    申请日：2003-09-17

    申请人： Jian Wang ,  Jingyi Wang

    发明人： Jian Wang ,  Jingyi Wang

    IPC分类号： A61N2/00 ,  A61N1/00

    CPC分类号： A61N2/06 ,  A61H23/0218 ,  A61H2201/10 ,  A61N2005/066

    摘要： Disclosed is a dynamic and static magnetic pulse physical therapeutic apparatus which can provide an energy superposition field of dynamic magnetic pulses including mechanical vibration, a pulse magnetic field, a permanent magnetic field, thermal radiation and far infrared radiation and an energy superposition field of static magnetic pulses including a pulse magnetic field, a permanent magnetic field, thermal radiation and far infrared radiation, individually or at the same time. It includes a shell, a far infrared radiation fin with a heating device, a plurality of annular permanent magnets and a control circuit; a dynamic magnetic pulse assembly or a static magnetic pulse assembly is provided at the center of the annular permanent magnet. The massage to the human body with a dynamic magnetic pulse energy field and a static magnetic pulse energy field of synchronous frequency makes the main and collateral channels of different parts of the human body receive synchronous massages of different forms and thus have obvious functions and improved curative effects on main and collateral channels deroppilation, activating blood and absorbing clots.

    摘要翻译： 公开了一种动态和静态磁脉冲物理治疗装置，其可以提供包括机械振动，脉冲磁场，永久磁场，热辐射和远红外辐射的动态磁脉冲的能量叠加场和静磁力的能量叠加场 单独地或同时地包括脉冲磁场，永久磁场，热辐射和远红外辐射的脉冲。 它包括壳体，具有加热装置的远红外辐射翅片，多个环形永磁体和控制电路; 在环形永磁体的中心设有动态磁脉冲组件或静磁脉冲组件。 用动态磁脉冲能量场和同步频率的静磁脉冲能量场对人体进行按摩使得人体不同部位的主要和旁路通道具有不同形式的同步按摩，具有明显的功能和改进的治疗 对主要和附带通道的破坏，激活血液和吸收凝块的影响。

    Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
    3.
    发明授权
    Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof 有权
    哌啶酮双层渗透泵控释片及其制备方法

    公开(公告)号：US08920835B2

    公开(公告)日：2014-12-30

    申请号：US13512402

    申请日：2010-11-22

    申请人： Yong Gan ,  Chunliu Zhu ,  Qingmin Yang ,  Jingyi Wang ,  Xiaoqing Zheng ,  Li Gan ,  Xinxin Zhang

    发明人： Yong Gan ,  Chunliu Zhu ,  Qingmin Yang ,  Jingyi Wang ,  Xiaoqing Zheng ,  Li Gan ,  Xinxin Zhang

    IPC分类号： A61K9/24 ,  A61K9/28 ,  A61K31/519 ,  A61P25/18 ,  B05D5/00 ,  A61K9/00 ,  A61K9/20 ,  A61K31/517

    CPC分类号： A61K9/0004 ,  A61K9/2086 ,  A61K9/2866 ,  A61K31/517

    摘要： A paliperidone double-layered osmotic pump controlled release tablet and the preparation method thereof are disclosed. The double-layered osmotic pump controlled release tablet comprises a rigid membrane, a push layer, a drug layer, an isolation layer and an aesthetic coating, wherein the rigid membrane contains a semi-permeable polymer, a porogen and/or a plasticizer and has one or more drug release orifices on one end, the push layer comprises an expanding material, an osmotic agent, a binder, a colorant and a lubricant, the drug layer contains a pharmaceutically active ingredient, a hydrophilic polymer, an osmotic agent, a colorant, a lubricant and an antistatic agent, the isolation layer is located between the inner surface of the rigid membrane and the push layer, and contains a hydrophilic polymer. The paliperidone double-layered osmotic pump controlled release tablet shows an increasing drug release rate at early stage and keeps a constant drug release rate at later stage.

    摘要翻译： 披露了一种帕培酮双层渗透泵控释片及其制备方法。 双层渗透泵控制释放片剂包括刚性膜，推层，药物层，隔离层和美容涂层，其中刚性膜含有半透性聚合物，致孔剂和/或增塑剂，并且具有 一个或多个药物释放孔在一端，推层包括膨胀材料，渗透剂，粘合剂，着色剂和润滑剂，药物层含有药物活性成分，亲水性聚合物，渗透剂，着色剂 ，润滑剂和抗静电剂，隔离层位于刚性膜的内表面和推层之间，并含有亲水性聚合物。 帕潘立酮双层渗透泵控释片剂在早期阶段呈现出药物释放速率的增加，药物释放速率在后期保持不变。

    PALIPERIDONE DOUBLE-LAYERED OSMOTIC PUMP CONTROLLED RELEASE TABLET AND PREPARATION METHOD THEREOF
    6.
    发明申请
    PALIPERIDONE DOUBLE-LAYERED OSMOTIC PUMP CONTROLLED RELEASE TABLET AND PREPARATION METHOD THEREOF 有权
    PALIPERIDONE双层OSMOTIC泵控制释放片及其制备方法

    公开(公告)号：US20120301547A1

    公开(公告)日：2012-11-29

    申请号：US13512402

    申请日：2010-11-22

    申请人： Yong Gan ,  Chunliu Zhu ,  Qingmin Yang ,  Jingyi Wang ,  Xiaoqing Zheng ,  Li Gan ,  Xinxin Zhang

    发明人： Yong Gan ,  Chunliu Zhu ,  Qingmin Yang ,  Jingyi Wang ,  Xiaoqing Zheng ,  Li Gan ,  Xinxin Zhang

    IPC分类号： A61K9/24 ,  B05D5/00 ,  A61P25/18 ,  A61K9/28 ,  A61K31/519

    CPC分类号： A61K9/0004 ,  A61K9/2086 ,  A61K9/2866 ,  A61K31/517

    摘要： A paliperidone double-layered osmotic pump controlled release tablet and the preparation method thereof are disclosed. The double-layered osmotic pump controlled release tablet comprises a rigid membrane, a push layer, a drug layer, an isolation layer and an aesthetic coating, wherein the rigid membrane contains a semi-permeable polymer, a porogen and/or a plasticizer and has one or more drug release orifices on one end, the push layer comprises an expanding material, an osmotic agent, a binder, a colorant and a lubricant, the drug layer contains a pharmaceutically active ingredient, a hydrophilic polymer, an osmotic agent, a colorant, a lubricant and an antistatic agent, the isolation layer is located between the inner surface of the rigid membrane and the push layer, and contains a hydrophilic polymer. The paliperidone double-layered osmotic pump controlled release tablet shows an increasing drug release rate at early stage and keeps a constant drug release rate at later stage.

    摘要翻译： 披露了一种帕培酮双层渗透泵控释片及其制备方法。 双层渗透泵控制释放片剂包括刚性膜，推层，药物层，隔离层和美容涂层，其中刚性膜含有半透性聚合物，致孔剂和/或增塑剂，并且具有 一个或多个药物释放孔在一端，推层包括膨胀材料，渗透剂，粘合剂，着色剂和润滑剂，药物层含有药物活性成分，亲水性聚合物，渗透剂，着色剂 ，润滑剂和抗静电剂，隔离层位于刚性膜的内表面和推层之间，并含有亲水性聚合物。 帕潘立酮双层渗透泵控释片剂在早期阶段呈现出药物释放速率的增加，药物释放速率在后期保持不变。

    COMPOUND FOR TREATING SEQUELAE OF ISCHEMIC CEREBRAL STROKE
    7.
    发明申请
    COMPOUND FOR TREATING SEQUELAE OF ISCHEMIC CEREBRAL STROKE 审中-公开
    用于治疗脑缺血发作的序列的化合物

    公开(公告)号：US20170044212A1

    公开(公告)日：2017-02-16

    申请号：US15236055

    申请日：2016-08-12

    申请人： Jingyi Wang

    发明人： Jingyi Wang ,  Jianling Zuo ,  Xiaoliang Lv ,  Tan Zhang

    IPC分类号： C07K7/06 ,  A61K38/08

    CPC分类号： C07K7/06 ,  A61K38/00 ,  A61K38/08

    摘要： The present invention provides a compound (I) for treating sequelae of ischemic cerebral stroke: H—(NH—CHR1—CO)—(NH—CHR2—CO)—(NH—CHR3—CO)—(NH—CHR4—CO)—(NH—CHR5—CO)—(NH—CHR6—CO)—(NH—CHR7—CO)—OH  (I) or a pharmaceutically acceptable salt thereof, wherein R1-R7 are defined herein. The present invention also provides a pharmaceutical composition comprising said compound and use of the same in the manufacture of a medicament for treating sequelae of ischemic cerebral stroke. The compound and pharmaceutical composition according to the present invention have good pharmacological activities so that they are able to improve significantly the symptom of sequelae of ischemic cerebral stroke.

    摘要翻译： 或其药学上可接受的盐，其中R 1 -R 7在本文中定义。 本发明还提供了包含所述化合物的药物组合物及其在制备用于治疗缺血性脑卒中后遗症的药物中的用途。 根据本发明的化合物和药物组合物具有良好的药理活性，使得它们能够显着改善缺血性脑卒中后遗症状。